全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

艾滋病相关性肿瘤研究进展

Keywords: 艾滋病,卡波西肉瘤,非霍奇金淋巴瘤,抗病毒,免疫重建

Full-Text   Cite this paper   Add to My Lib

Abstract:

卡波西肉瘤、非霍奇金淋巴瘤及侵入性宫颈癌被命名为艾滋病相关性肿瘤,该文介绍了上述肿瘤现代医学研究进展,提出抗病毒、免疫重建及抗肿瘤是艾滋病相关性肿瘤治疗的关键因素。中医药在减轻艾滋病抗病毒药物的不良反应、发挥抗病毒作用、调节患者免疫功能、配合化放疗减毒增效以及稳定肿瘤病灶等方面能够发挥作用,根据患者免疫功能、治疗阶段等因素,制定合理的综合治疗策略,整体治疗和个体化治疗相结合,将有助于提高艾滋病相关性肿瘤患者的生存质量,延长生存期。

References

[1]  罗艳,何艳,姚运海,等.八珍汤改善艾滋病高效抗逆转录病毒治疗所致血液毒副反应的临床观察[J].中国中西医结合杂志,2012,32(12):1704.
[2]  Barbaro G,Barbarini G. HIV infection and cancer in the era of higllly active antirelroviral therapy[J]. Oncol Rep,2007,17(5):1121.
[3]  Roth W K. Cellular and molecular featurs of HIV-addociated Kaposi\'s sarcoma[J].AIDS,1992,6:895.
[4]  Cooley T,Henry D,Tonda M,et al.A randomized,double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi\'s sarcoma[J].Oncologist,2007,12(1):114.
[5]  Krause J.AIDS-related non-Hodgkin\'s lymphomas[J]. Microscopy Res Technique,2005,68(3/4):168.
[6]  Knowles D M. Etiology and pathogenesis of AIDS-related non-Hodgkin\'s lymphoma[J].Hematol Oncol Clin North Am,2003,17(3): 785.
[7]  Josep-Maria Ribera,José Tomás Navarro. Human immunodeficiency virus-related non-Hodgkin\'s lymphoma[J]. Haematologica,2008,93(8): 1129.
[8]  Chia-Ching Wang,Jorge J,Castillo. Patients with HIV-associated lymphomast should be treated by HIV oncologists in settings where they can benefit from research protocols[J].Manage HIV-Assoc Lymphomas,2011,94(1): 4.
[9]  徐航娣,周韧. AIDS 伴发的淋巴瘤的研究进展[J].国际病理学与临床杂志,2006,26(3): 222.
[10]  Oriol A,Ribera J M,Bergua J,et al. High-dose chemotherapy and immunothempy in adult Burkitt lymphoma comparison of results in human immunodeficiency virus-infected and noninfected patients[J].Cancer,2008,113(1): 117.
[11]  Ribera J M,Oriol A,Morgades M,et al. Safety and efficacy of cyclophosphamide,adriamycin,vincristine,prednisone and rituximab in patients with human immunodeficiency virus-asseciated diffuse large B-cell lymphoma: results of a phase II trial[J].Br J Haematol,2008,140(4): 411.
[12]  张仁芳,卢洪洲. 获得性免疫缺陷综合征相关性肿瘤治疗进展[J]. 医药专论,2010,31(6): 334.
[13]  Mounier N,Spina M,Gabarre J,et al. AIDS-related non-Hodgkin lymphoma[J].Blood,2006,107(10): 3832.
[14]  Vaccher E,Spina M,di Genaro G,et al. Concomitant cyclophosphamide,doxorubicin,vincristine and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related non-Hodgkin\'s lymphoma[J]. Cancer,2001,91(1): 155.
[15]  Little R F,Pittaluga S,Grant N,et al. Highly effective treatment of acquired inmmunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology[J].Blood,2003,101(12): 4653.
[16]  Chia-Ching Wang,Jorge J,Castillo. Patients with HIV-associated lymphomas should be treated by HIV oncologists in settings where they can benefit from research protocols[J].Manage HIV-Assoc Lymphomas,2011,94(1): 4.
[17]  Sparano J A. HIV-associated lymphoma: the evidence for treating aggressively but withcaution[J].Curr Opin Oncol,2007,19(5): 458.
[18]  Lim S T,Karim R,Nathwani B N,et al. AIDS-related Burkitt\'s lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiret-roviral therapy (HAART) and HAART eras[J].J Clin Oncol,2005,23(19): 4430.
[19]  Perkins A S,Friedberg J W. Burkitt lymphoma in adult[M]. Hematol Am Soc Hematol Educ Program,2008: 341.
[20]  CDC. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults [EB/OL]. [1992-12-18].http://www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm.
[21]  World Health Organization.IARC working group on the evaluation of carcinogenic risks to humans. Human immunodeficiency viruses and human T2cell lymphotropic viruses. IARC monographs on the evaluation of carcinogenic risks to humans[M]. Lyon:IARC,1996.
[22]  Dal Maso L, Serraino D, Franceschi S. Epidemiology of AIDS2 related tumors in developed and developing countries[J]. Eur J Cancer, 2001, 37:1188.
[23]  Shrivastava S K,Engineer R,Rajadhyaksha S,et al.HIV infection and invasive cervical cancers, treatment with radiation therapy: toxicity and outcome[J].Radiother Oncol, 2005,74(1):31.
[24]  钟崇方,王芳,叶恒波,等.艾滋病抗病毒治疗药物副作用探讨[J].中国艾滋病性病,2009,15(3):298.
[25]  熊卫标,伍兰萼.中西医结合治疗艾滋病抗病毒治疗后皮疹疗效观察[J].实用中西医结合临床,2012,12(1):37.
[26]  樊移山,周曾全,李侠,等.中医药治疗艾滋病抗病毒治疗后肝损伤41 例[J].北京中医药,2010,29(7):547.
[27]  李强,翟春苗.化痰泻浊法治疗高效抗反转录病毒疗法后高脂血症临床分析[J].辽宁中医杂志,2012,39(5):880.
[28]  张政,王福生. AIDS 的免疫重建和免疫治疗[J].传染病信息,2009,22(6): 325.
[29]  王阶,林洪生,李勇,等.免疫2号方对艾滋病免疫重建不全患者临床症状、体征的影响[J].中医杂志,2012,53(11):923.
[30]  兰金初,李德益,阴忠起.三归片治疗艾滋病临床研究[J].河南中医学院学报,2005,20(1):11.
[31]  刘继明. 针刺与耳针治疗24 例艾滋病患者临床观察[J].针灸临床杂志,1999(15): 24.
[32]  彭勃,王丹妮.灸法改善AIDS 患者症状的临床研究[J].河南中医学院学报,2006,21(5): 1.
[33]  Asres K,Seyoum A,Veeresham C, et al. Naturally derivedanti-HIV agents[J].Phytother Res,2005,19(7): 557.
[34]  邓联柏,李爱秀,靳玉瑞,等.抗艾滋病复方中单味中药的运用情况分析[J].中医学报,2013,28(177):155.
[35]  周雅萍,王明艳. 中医药抗病毒感染的研究进展[J].中医学报, 2012,27(173): 1300.
[36]  林洪生,李道睿. 参芪扶正注射液提高非小细胞肺癌化疗患者生存质量的随机对照多中心临床试验[J].中华肿瘤杂志,2009,29(12): 931.
[37]  石闻光,侯炜,周雍明. 益气养阴活血方对鼻咽癌放疗后涎腺功能的影响[J].中国中西医结合外科杂志, 2008, 14(5):439.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133